Practical Aspects of Vaginal Brachytherapy for Endometrial Cancer

In this session, we review the practical aspects of VBT planning including choice of applicators, dose, prescription and planning. We include and discuss cases and provide tips to build a brachytherapy program. In addition, presenters highlight the underutilization of brachytherapy, disparity in treatment and access to patients. Finally, we discuss the challenges being faced in light of new immunotherapy clinical trials. 

The content was originally presented and recorded as a live webinar series on September 4 and September 11, 2024.

Target Audience

This activity is designed to meet the interests of radiation oncologists, medical oncologists and radiation oncology residents. 

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

  • Define who are (and who are not) appropriate candidates for VBT.
  • Recognize the underutilization of brachytherapy
  • Discuss treatment disparities and access to patients.
  • Understand the practical and technical aspects of vaginal brachytherapy
  • Implement a successful VBT at their program 
  • Efficiently deliver high-quality VBT.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.
Course opens: 
07/25/2024
Course expires: 
10/09/2026
Cost:
$0.00
Part of: 
How to Optimally Deliver Vaginal Cuff Brachytherapy for Endometrial Cancer in Your Practice: Tips and Tricks From the Experts
Rating: 
0
  • Lara Hathout, MD, FRCPC, is employed by Rutgers Cancer Institute of New Jersey. Dr. Hathout receives compensation as a consultant from the RTOG Foundation. 
  • Matthew Harkenrider, MD, is employed by Loyola University Medical Center. Dr. Harkenrider receives compensation as a consultant from the RTOG Foundation and from NEED. 
  • Idalid Ivy Franco, MD, MPH, is employed by Brigham and Women's Hospital/Dana-Farber Cancer Institute. Dr. Franco receives grant/research funding from the National Cancer Institute, NIH/NCI, Brigham and Women's Hospital/Dana-Farber Cancer Institute and ASTRO/RTOG NRG Oncology Health Equity Fellowship. Dr. Franco is Executive Vice Chair of the Equity and Inclusion Subcommittee for ARRO and serves as Vice Chair of the Health Equity Education Committee for the Council on Health Equity Diversity and Inclusion with ASTRO.
Disclosure link: 
Committee Disclosure

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.